SHEILA BLALOCK: Open Payments
NPI 1952625030 · CROSSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,931 in 128 payments from 18 companies in 2025. Trend: 2023 $1,874 · 2024 $2,348 · 2025 $1,931
Food & beverage: $1,931
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $337 |
| PFIZER INC. | 25 | $318 |
| Novo Nordisk Inc | 16 | $234 |
| GlaxoSmithKline, LLC. | 11 | $169 |
| Lilly USA, LLC | 12 | $155 |
| AstraZeneca Pharmaceuticals LP | 6 | $150 |
| Axsome Therapeutics, Inc. | 7 | $130 |
| Antares Pharma, Inc. | 4 | $97 |
| Xeris Pharmaceuticals, Inc. | 3 | $57 |
| Lundbeck LLC | 2 | $55 |
Products named: UBRELVY, TRELEGY ELLIPTA, NURTEC ODT, ELIQUIS, Ozempic, Auvelity, VRAYLAR, MOUNJARO.
Industry payments across TN — which companies pay providers there.
